Furthermore, elevated anti-ANO2 antibody titers were observed in MS patients when compared with EBV-positive controls, suggesting a potential role for EBNA1 and ANO2 antigens in terms of molecular mimicry. The gene discussed is ANO2; the disease is myeloid sarcoma.